The Butantan Institute exports flu vaccine batches to Uruguay and Nicaragua. In total, 925,000 doses will be made available to the two nations in order to strengthen the stock of immunizing agents against the influenza virus.
The first batch has already been shipped. About 225,000 doses were sent to Nicaragua. Uruguay will receive the remaining 700,000 doses.
The Butantan vaccine is called “trivalent”. The name is given by the ability to generate immune responses against three variants of the influenza virus: H1N1, the B strain and H3N2. This last type caused several cases in Brazil last year.
The research institution was selected in a public tender issued by the Pan American Health Organization (PAHO), representing the World Health Organization (WHO) for the region. Butantan was accepted because its flu vaccine was included in a PAHO immunization list.
The Butantan Institute’s influenza vaccine is also used in vaccination in Brazil.
Translated to english by RJ983
From Brazil, by EBC News